Additional cost savings beyond those found in the study would be expected due to medication non-compliance, ocular surface disease caused by medication and preservatives, and decreasing effectiveness of medication/drug therapy (tachyphylaxis) and medication side effects, especially in patients requiring multiple glaucoma medications.